TABLE 1.
Clinical characteristics of patients and tissue samples
| Characteristic | Result for histological categorya |
||
|---|---|---|---|
| PCC (n = 82) | BPH (n = 34) | Normal (n = 32) | |
| Age (yrs) | |||
| Median | 66 | 65 | 65 |
| Range | 47-75 | 50-80 | 44-83 |
| Serum total PSA (ng/ml) | NA | ||
| Median | 10.24 | 3.7 | |
| Range | 0.01-256 | 0.15-21.88 | |
| No. (%) with PSA range of: | |||
| <4 | 8 (10) | 20/34 (59) | |
| 4.1-8 | 24 (29) | 7/34 (21) | |
| 8.1-12 | 17 (21) | 5/34 (15) | |
| >12 | 30 (37) | 2/34 (6) | |
| Unknown | 3 | 0 | |
| No. (%) at pathological stage: | NA | NA | |
| T2a | 4 (5) | ||
| T2b | 3 (4) | ||
| T2c | 22 (26) | ||
| T3a | 24 (29) | ||
| T3b | 29 (35) | ||
| Gleason sum | NA | NA | |
| Median | 7 | ||
| Range | 5-10 | ||
| No. (%) with sum of: | |||
| 5 | 4 (5) | ||
| 6 | 8 (10) | ||
| 7 | 43 (52) | ||
| 8 | 12 (15) | ||
| 9-10 | 15 (18) | ||
a
PSA, prostate-specific antigen; PCC, prostate cancer cells; NA, not applicable.